Due to the combined effects of technological revolution and green transformation, the heterocyclic intermediate business is transforming from a "basic chemical raw material supplier" to a "designer of high-end functional materials". By applying cutting-edge technologies such as biocatalysis and intelligent control to the industrial sector, we have continuously explored blue ocean markets such as new energy and bio-based materials. At the same time, relying on the core technology of "precise synthesis + continuous iteration", we have consolidated our advantages in the pharmaceutical and electronics industries. From 2025 to 2030, during the entire industry integration era, the company will leverage this "technology leading demand, and demand driving innovation" virtuous cycle to promote itself to establish a global benchmark position within the industry.